Supernus Pharmaceuticals Inc (NASDAQ:SUPN)
| 29.72 Delayed Data As of 4:00pm ET |  +0.52 / +1.78%Today’s Change | 23.15 Today|||52-Week Range 34.50 | +1.92% Year-to-Date |
Latest SUPN News | Press Releases
No recent news for Supernus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 29.20 |
| Today’s open | 28.44 |
| Day’s range | 28.44 - 29.79 |
| Volume | 19,253 |
| Average volume (3 months) | 413,291 |
| Market cap | $1.6B |
Data as of 4:00pm ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | +11.85% |
| Earnings growth (this year) | -42.80% |
| Earnings growth (next 5 years) | -22.60% |
| Revenue growth (last year) | +32.50% |
| P/E ratio | 19.7 |
| Price/Sales | 2.60 |
| Price/Book | 2.09 |
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | $0.26 |
| Annual revenue (last year) | $520.4M |
| Annual profit (last year) | $127.0M |
| Net profit margin | 24.39% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
